Sanofi (SNY) Sales of Property, Plant and Equipment (2013 - 2021)

Sanofi (SNY) Sales of Property, Plant and Equipment (2013 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 36.40 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 29.00 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -
10 Sanofi 59.75 Mn -6.87 Bn 9.49 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2021 800,779.67
Dec 31, 2021 800,779.67
Dec 31, 2020 119,228.98
Dec 31, 2020 119,228.98
Dec 31, 2019 774,821.37
Dec 31, 2019 774,821.37
Dec 31, 2018 558.14 Mn
Dec 31, 2018 558.14 Mn
Sep 30, 2018 1.86 Bn
Sep 30, 2018 1.86 Bn
Dec 31, 2017 480.39 Mn
Dec 31, 2017 480.39 Mn
Jun 30, 2013 402.17 Mn
Jun 30, 2013 402.17 Mn